Progress in the research of GPIIb/IIIa antagonists.

about

The progress in the research of antiplatelet agents (1995-2017).A Short Half-Life αβ₃ Antagonist ANTP266 Reduces Thrombus Formation

P2860

Q38669003-EC69E99E-3BFD-4B1F-BE79-F5EC34546659 Q58798481-84AB9BE6-1DBF-4011-8994-ADFAD90EFA75

P2860

Progress in the research of GPIIb/IIIa antagonists.

Item

http://www.wikidata.org/entity/Q38541493

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Progress in the research of GPIIb/IIIa antagonists.

@en

type

Item

label

Progress in the research of GPIIb/IIIa antagonists.

@en

prefLabel

Progress in the research of GPIIb/IIIa antagonists.

@en

P1476

Progress in the research of GPIIb/IIIa antagonists.

@en

P2093

Chen Cao

http://www.w3.org/2001/XMLSchema#string

Jing Huang

http://www.w3.org/2001/XMLSchema#string

Sen Feng

http://www.w3.org/2001/XMLSchema#string

Zhiyu Li

http://www.w3.org/2001/XMLSchema#string

Zhouling Xie

http://www.w3.org/2001/XMLSchema#string

P2860

Closed headpiece of integrin IIb 3 and its complex with an IIb 3-specific antagonist that does not induce opening

Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetic: distinct binding profile for Roxifiban

Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention.

Profound thrombocytopenia associated with tirofiban: case report and review of literature.

Identification and characterization of antibodies that bind GPIIb/IIIa: antagonist complexes.

Relation of periprocedural bleeding complications and long-term outcome in patients undergoing percutaneous coronary revascularization (from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial).

Antiplatelet therapies: from aspirin to GPIIb/IIIa-receptor antagonists and beyond.

A critical appraisal of platelet glycoprotein IIb/IIIa inhibition.

Structure-based virtual screening of small-molecule antagonists of platelet integrin αIIbβ3 that do not prime the receptor to bind ligand

The interaction of integrin αIIbβ3 with fibrin occurs through multiple binding sites in the αIIb β-propeller domain.

P304

1149-1171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/FMC.15.53

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26132524

http://www.w3.org/2001/XMLSchema#string

Progress in the research of GPIIb/IIIa antagonists.

about

P2860

P2860

Progress in the research of GPIIb/IIIa antagonists.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698